Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Takhzyro


To avoid
As a precautionary measure

To avoid
Use with caution
Takhzyro :
Type Medicine Authorised
Originator Biotech (Takhzyro)
Agent Abela Freres
Distributor Abela Freres
Laboratory Takeda
Responsible Party Shire Pharmaceuticals Ireland Limited
Origin Ireland
Manufacturer Catalent Indiana LLC
Origin U.S.A.
ATC B06AC05

Your comment will appear shortly after approval

Takhzyro :

Revision Date : 03/09/2020


Effect Frequency
ALT increased Common
AST increased Common
Dizziness Common
Hypersensitivity Common
Injection site reaction Very Common
Maculopapular rash Common
Myalgia Common

Different Units By MoH Code

Takhzyro  MoH 10626 :
Form Solution for injection
Package Size 1x2ml
Strength 300mg
Storage Condition 2-8°C Do not freeze
Public Price 19752269 L.L.
Stratum E2
NSSF ✘
Quarantine ✘
Reg. Number 141720/1
Submission date 30/09/2020
Registration Year 20/05/2021


Price Comparison

● Country: Kuweit
● Package Size: 1x2ml
● Public Price: 6852.4 KWD ( 2,011,734,444.40 LBP )
● Pack size unit used: 1
● Cost/Unit: 6852,4 KWD ( 2,011,617,012.00 LBP )
● Pharmacy Price: 5789.1 KWD ( 1699569767.1 LBP )
● Pricing Date: 07/02/2021
● Type: Medicine Authorised

● Country: Abu Dhabi
● Package Size: 1x2ml
● Public Price: 78607.5 AED ( 1,899,235,807.50 LBP )
● Pack size unit used: 1
● Cost/Unit: 78607,5 AED ( 1,899,223,727.00 LBP )
● Pharmacy Price: 66962 AED ( 1617868882 LBP )
● Pricing Date: 27/01/2021
● Type: Medicine Authorised

● Country: Denmark
● Package Size: 1x2ml
● Public Price: 133860 DKK ( 1,736,967,360.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 133860 DKK ( 1,736,967,360.00 LBP )
● Pharmacy Price: 99519.09 DKK ( 1291359711.84 LBP )
● Reference: Danish Medicine Agency
● Pricing Date: 19/05/2021
● Type: Medicine Authorised

● Country: Finland
● Package Size: 1x2ml
● Public Price: 15438.78 EUR ( 1,495,647,251.28 LBP )
● Pack size unit used: 1
● Cost/Unit: 15438,78 EUR ( 1,495,571,688.00 LBP )
● Reference: Kela
● Pricing Date: 18/05/2021
● Type: Medicine Authorised

● Country: Switzerland
● Package Size: 1x2ml
● Public Price: 14191.25 CHF ( 1,467,659,075.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 14191,25 CHF ( 1,467,633,220.00 LBP )
● Exfactory Price: 13605.13 CHF
● Pricing Date: 04/04/2021
● Type: Medicine Authorised

● Country: Norway
● Package Size: 1x2ml
● Public Price: 177375.3 NOK ( 1,437,449,431.20 LBP )
● Pack size unit used: 1
● Cost/Unit: 177375,3 NOK ( 1,437,447,000.00 LBP )
● Pharmacy Price: 138411 NOK ( 1121682744 LBP )
● Reference: Norwegian Medicine Agency
● Pricing Date: 01/04/2020
● Type: Medicine Authorised

● Country: UK
● Package Size: 1x2ml
● Public Price: 12420 GBP ( 1,411,520,580.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 12420 GBP ( 1,411,520,580.00 LBP )
● Reference: DMD
● Pricing Date: 08/03/2021
● Type: Medicine Authorised

● Country: KSA
● Package Size: 1x2ml
● Public Price: 52774.452 SAR ( 1,247,588,045.28 LBP )
● Pack size unit used: 1
● Cost/Unit: 52774,452 SAR ( 1,247,577,360.00 LBP )
● Reference: sfda
● Pricing Date: 16/01/2021
● Type: Medicine Authorised

● Country: France
● Package Size: 1x 2ml
● Public Price: 11855 EUR ( 1,148,464,980.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 11855 EUR ( 1,148,464,980.00 LBP )
● Reference: ansm
● Pricing Date: 15/05/2021
● Type: Medicine Authorised

● Country: Lebanon
● Form: Solution for injection
● Package Size: 1x2ml
● Public Price: 19752269 LBP ( 19,752,269.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 19752269 LBP ( 19,752,269.00 LBP )
● Pricing Date: 13/06/2024

● Country: Spain
● Package Size: 1x2ml
● Reference: Agencia Española de Medicamentos y Productos Sanitarios
● Pricing Date: 06/05/2021
● Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries

Note

Prevention of recurrent attacks of hereditary angioedema : (Adults)
● Cost/Unit: 6852,4 KWD ( 2,011,617,012.00 LBP )
● Cost/Day: 6852,4 KWD ( 2,011,617,012.00 LBP )
● Cost/Month: 13704,8 KWD ( 4,023,234,024.00 LBP )
Prevention of recurrent attacks of hereditary angioedema : (Children)
● Cost/Unit: 6852,4 KWD ( 2,011,617,012.00 LBP )
● Cost/Day: 6852,4 KWD ( 2,011,617,012.00 LBP )
● Cost/Month: 13704,8 KWD ( 4,023,234,024.00 LBP )
Prevention of recurrent attacks of hereditary angioedema : (Adults)
● Cost/Unit: 78607,5 AED ( 1,899,223,727.00 LBP )
● Cost/Day: 78607,5 AED ( 1,899,223,727.00 LBP )
● Cost/Month: 157215 AED ( 3,798,471,615.00 LBP )
Prevention of recurrent attacks of hereditary angioedema : (Children)
● Cost/Unit: 78607,5 AED ( 1,899,223,727.00 LBP )
● Cost/Day: 78607,5 AED ( 1,899,223,727.00 LBP )
● Cost/Month: 157215 AED ( 3,798,471,615.00 LBP )
Prevention of recurrent attacks of hereditary angioedema : (Adults)
● Cost/Unit: 133860 DKK ( 1,736,967,360.00 LBP )
● Cost/Day: 133860 DKK ( 1,736,967,360.00 LBP )
● Cost/Month: 267720 DKK ( 3,473,934,720.00 LBP )
Prevention of recurrent attacks of hereditary angioedema : (Children)
● Cost/Unit: 133860 DKK ( 1,736,967,360.00 LBP )
● Cost/Day: 133860 DKK ( 1,736,967,360.00 LBP )
● Cost/Month: 267720 DKK ( 3,473,934,720.00 LBP )
Prevention of recurrent attacks of hereditary angioedema : (Adults)
● Cost/Unit: 15438,78 EUR ( 1,495,571,688.00 LBP )
● Cost/Day: 15438,78 EUR ( 1,495,571,688.00 LBP )
● Cost/Month: 30877,56 EUR ( 2,991,240,252.00 LBP )
Prevention of recurrent attacks of hereditary angioedema : (Children)
● Cost/Unit: 15438,78 EUR ( 1,495,571,688.00 LBP )
● Cost/Day: 15438,78 EUR ( 1,495,571,688.00 LBP )
● Cost/Month: 30877,56 EUR ( 2,991,240,252.00 LBP )
Prevention of recurrent attacks of hereditary angioedema : (Adults)
● Cost/Unit: 14191,25 CHF ( 1,467,633,220.00 LBP )
● Cost/Day: 14191,25 CHF ( 1,467,633,220.00 LBP )
● Cost/Month: 28382,5 CHF ( 2,935,266,440.00 LBP )
Prevention of recurrent attacks of hereditary angioedema : (Children)
● Cost/Unit: 14191,25 CHF ( 1,467,633,220.00 LBP )
● Cost/Day: 14191,25 CHF ( 1,467,633,220.00 LBP )
● Cost/Month: 28382,5 CHF ( 2,935,266,440.00 LBP )
Prevention of recurrent attacks of hereditary angioedema : (Adults)
● Cost/Unit: 177375,3 NOK ( 1,437,447,000.00 LBP )
● Cost/Day: 177375,3 NOK ( 1,437,447,000.00 LBP )
● Cost/Month: 354750,6 NOK ( 2,874,894,000.00 LBP )
Prevention of recurrent attacks of hereditary angioedema : (Children)
● Cost/Unit: 177375,3 NOK ( 1,437,447,000.00 LBP )
● Cost/Day: 177375,3 NOK ( 1,437,447,000.00 LBP )
● Cost/Month: 354750,6 NOK ( 2,874,894,000.00 LBP )
Prevention of recurrent attacks of hereditary angioedema : (Adults)
● Cost/Unit: 12420 GBP ( 1,411,520,580.00 LBP )
● Cost/Day: 12420 GBP ( 1,411,520,580.00 LBP )
● Cost/Month: 24840 GBP ( 2,823,041,160.00 LBP )
Prevention of recurrent attacks of hereditary angioedema : (Children)
● Cost/Unit: 12420 GBP ( 1,411,520,580.00 LBP )
● Cost/Day: 12420 GBP ( 1,411,520,580.00 LBP )
● Cost/Month: 24840 GBP ( 2,823,041,160.00 LBP )
Prevention of recurrent attacks of hereditary angioedema : (Adults)
● Cost/Unit: 52774,452 SAR ( 1,247,577,360.00 LBP )
● Cost/Day: 52774,45 SAR ( 1,247,577,360.00 LBP )
● Cost/Month: 105548,9 SAR ( 2,495,154,720.00 LBP )
Prevention of recurrent attacks of hereditary angioedema : (Children)
● Cost/Unit: 52774,452 SAR ( 1,247,577,360.00 LBP )
● Cost/Day: 52774,45 SAR ( 1,247,577,360.00 LBP )
● Cost/Month: 105548,9 SAR ( 2,495,154,720.00 LBP )
Prevention of recurrent attacks of hereditary angioedema : (Adults)
● Cost/Unit: 11855 EUR ( 1,148,464,980.00 LBP )
● Cost/Day: 11855 EUR ( 1,148,464,980.00 LBP )
● Cost/Month: 23710 EUR ( 2,296,929,960.00 LBP )
Prevention of recurrent attacks of hereditary angioedema : (Children)
● Cost/Unit: 11855 EUR ( 1,148,464,980.00 LBP )
● Cost/Day: 11855 EUR ( 1,148,464,980.00 LBP )
● Cost/Month: 23710 EUR ( 2,296,929,960.00 LBP )
Prevention of recurrent attacks of hereditary angioedema : (Adults)
● Cost/Unit: 19752269 LBP ( 19,752,269.00 LBP )
● Cost/Day: 19752269 LBP ( 19,752,269.00 LBP )
● Cost/Month: 39504538 LBP ( 39,504,538.00 LBP )
Prevention of recurrent attacks of hereditary angioedema : (Children)
● Cost/Unit: 19752269 LBP ( 19,752,269.00 LBP )
● Cost/Day: 19752269 LBP ( 19,752,269.00 LBP )
● Cost/Month: 39504538 LBP ( 39,504,538.00 LBP )
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info